Deregulation of the differentiation program is likely responsible for the development of AD, although it is not sufficient, whereas disruption of the R-point program likely results in the abrogation of the ARF-p53 pathway-mediated oncogene surveillance mechanism, enabling the subsequent selection of K-RAS-mutated cells. This evidence concerns the gene CDKN2A and Alzheimer disease.